In Australia, Collagen Solutions PLC, which is registered in London and has global headquarters in Minnesota, received additional patent protection. The patent allows Collagen to source animal-based biomaterials from Australia for their pericardium tissue for heart valve replacements, orthopedics, dental industry, wound healing, surgery, and other medical uses. Australia and New Zealand are often sought-after by companies looking for high quality animal-based biomaterials because they have strict controls and have been doing it for a long time. Collagen’s CEO, Jamal Rushdy, told Proactive Investors UK, “This recent patent further strengthens our position in sourcing tissue in Australia in a novel way. We believe the additional processing covered in this patent will be of significant interest to our existing customer base.”
Latest article
New yoga fabric collection from Hyosung TNC and Lenzing “nama-stays” away from synthetic fibers
In South Korea, global elastane leader Hyosung TNC and Lenzing Group, a leading global producer of regenerated cellulosic fibers for the textile and nonwovens...
Egg carton kicks explore intersection of design and simplicity
In Prague, Kibardin Design has created a sneaker concept out of recycled egg cartons. Dubbed Egg Box Sneakers, the design project combines art, fashion...
Oyster waste provides pleasant “shell-ter” for Sydney parkgoers
In Sydney, Australia, a new Pier Pavilion designed by Besley & Spresser has been built using waste rock oyster shells.
Comprising a “striking landscape...